HLTH vs. STRM, UPHL, ONMD, TLIS, FORA, BFRG, GDTC, INDP, PYPD, and ONCT
Should you be buying Cue Health stock or one of its competitors? The main competitors of Cue Health include Streamline Health Solutions (STRM), UpHealth (UPHL), OneMedNet (ONMD), Talis Biomedical (TLIS), Forian (FORA), Bullfrog AI (BFRG), CytoMed Therapeutics (GDTC), Indaptus Therapeutics (INDP), PolyPid (PYPD), and Oncternal Therapeutics (ONCT). These companies are all part of the "medical" sector.
Cue Health (NASDAQ:HLTH) and Streamline Health Solutions (NASDAQ:STRM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment.
Streamline Health Solutions has a net margin of -81.36% compared to Cue Health's net margin of -526.48%. Streamline Health Solutions' return on equity of -29.25% beat Cue Health's return on equity.
Cue Health has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, Streamline Health Solutions has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500.
45.5% of Cue Health shares are held by institutional investors. Comparatively, 31.7% of Streamline Health Solutions shares are held by institutional investors. 12.5% of Cue Health shares are held by company insiders. Comparatively, 26.7% of Streamline Health Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Streamline Health Solutions received 223 more outperform votes than Cue Health when rated by MarketBeat users. Likewise, 51.97% of users gave Streamline Health Solutions an outperform vote while only 7.14% of users gave Cue Health an outperform vote.
Streamline Health Solutions has lower revenue, but higher earnings than Cue Health. Streamline Health Solutions is trading at a lower price-to-earnings ratio than Cue Health, indicating that it is currently the more affordable of the two stocks.
Cue Health presently has a consensus price target of $3.00, indicating a potential upside of 1,954.79%. Streamline Health Solutions has a consensus price target of $2.00, indicating a potential upside of 488.24%. Given Cue Health's higher probable upside, equities research analysts plainly believe Cue Health is more favorable than Streamline Health Solutions.
In the previous week, Streamline Health Solutions had 2 more articles in the media than Cue Health. MarketBeat recorded 2 mentions for Streamline Health Solutions and 0 mentions for Cue Health. Streamline Health Solutions' average media sentiment score of 0.22 beat Cue Health's score of 0.00 indicating that Streamline Health Solutions is being referred to more favorably in the news media.
Summary
Streamline Health Solutions beats Cue Health on 11 of the 16 factors compared between the two stocks.
Get Cue Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for HLTH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HLTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cue Health Competitors List
Related Companies and Tools
